DUBLIN, April 23, 2014 /PRNewswire/ --

Dublin - Research and Markets (http://www.researchandmarkets.com/research/zp88w2/2013_cro_quality) has announced the addition of the "2014 CRO Quality Benchmarking - Phase I Service Providers" report to their offering. 

     (Photo: http://photos.prnewswire.com/prnh/20130307/600769 )


In its 5th year, the "CRO Quality Benchmarking" series provides the pharmaceutical industry with a unique resource to evaluate and select CROs, while offering clinical service providers valuable insight into their service quality, their competitors' service quality, and their customers' outsourcing behaviors. This year, Phase I report includes data from 360 unique service evaluations across 23 Phase I service providers. 

MAJOR SECTIONS:

1. Outsourcing Behaviors, Attitudes, Beliefs, and Intentions
2. Service Provider Selection Drivers
3. Service Provider Performance and Scorecards across Attributes
4. Satisfaction, Customer Loyalty, and the Expectations and
5. Service Provider Service Quality Profiles
6. Study Data


Key Topics Covered: 

Copyright and Usage Guidelines 

Introduction 

Methodology 

Respondent Demographics 
Participant Years of Industry Experience 
Participant Geography 
Number of Ratings per Company 

Major sections 

Outsourcing Behaviors, Attitudes, Beliefs, and Intentions 
Phase I Leaders, unprompted 
Phase I Leaders, Prompted 
Received Proposals 
Service Provider Usage 
Service Provider Cost Perceptions 

Service Provider Selection Drivers 
Most Important Service Provider Attributes 
Service Provider Attributes Gaining Importance 

Service Provider Performance and Scorecards across Attributes 

Outcome Measures: EPI and Customer Loyalty 
Summary of EPI 30 Service Provider Loyalty - A compilation of Overall Satisfaction, Willingness to Recommend, and Likelihood to Use Again 

Company Service Quality Profiles 
Celerion 
Charles River 
Covance 
ICON 
InVentiv Health Clinical 
Medpace 
PAREXEL 
PPD 
PRA 
PRACS Institute 
Quintiles 
WCCT 

Study Data 
Phase I 
Phase I Leaders, unprompted 
Phase I Leaders, Prompted 
Received Proposals 
Most Important Service Provider Attributes 
Service Provider Attributes Gaining Importance 
Service Provider Usage 
Service Provider Preference 
Best Service Provider at Differentiation 
Service Provider Cost Experience 
Service Provider Cost Experience by users of past 18 months 
Summary of EPI 
Service Provider Loyalty 

Service Provider Loyalty - A compilation of Overall Satisfaction, Willingness to Recommend, and Likelihood to Use Again 
Overall Satisfaction with Service Providers 
Willingness to Recommend Service Providers 
Likelihood to Use Service Providers Again 

Service Providers Drill-downs 
CEDRA 
Celerion 
Charles River 
Chiltern 
Covance 
DaVita 
DCRI-Duke 
ICON 
INC Research 
InVentiv Health Clinical 
Medpace 
PAREXEL 
PPD 
PRA 
PRACS Institute 
Premier Research 
Quintiles 
Rho 
SGS Life Sciences 
Siro Clinpharm 
Theorem 
US Oncology 
WCCT 

Cross-service provider performance 
Access to unique tests, machines, equipment 
Access to a broad range of services beyond clinic / volunteer management
Access to patient populations 
Data quality 
Experience of the Phase I unit's lead investigator 
Financial strength/ stability 
Local market / Regulatory knowledge 
Location of Phase I unit(s) in different global region 
Location of Phase I unit(s) within your country 
Low cost 
Meeting database lock timelines 
Meeting first patient / first visit timelines 
Meeting overall project timelines 
Minimizing change orders 
Minimizing staff turnover 
Offered innovative solutions 
Overall value 
Patient/ volunteer recruitment 
Positive experience with service provider 
Project manager quality 
Project team chemistry 
Scientific knowledge 
Speed of site / Investigator recruitment 
Speed of site start-up 
Technology for real-time access to data 
Therapeutic expertise 
Timely access to open bed / clinic space 
Timely project communications 
Up-front contingency planning, risk management 

Trade-Offs 

Respondent Demographics 
Company Type 
Primary Area of Responsibility 
Outsourcing Responsibility 
Job Title 
Recent Activity in Outsourced Activities 
Phase Responsibility 
Involvement in Clinical Development Process 
Years in the Industry 
Location 
Therapeutic Area 


For more information visit http://www.researchandmarkets.com/research/zp88w2/2013_cro_quality

Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net

SOURCE Research and Markets